Drug or treatment

Ranibizumab clinical trials

• 6Clinical trials
• 22Countries

Newest trials

All recruiting trials (6)

• SMZ1 plus ranibizumab vs placebo plus ranibizumab for wet AMD without PCV

  A study tests whether SMZ1 tablets added to ranibizumab can give better vision improvement than placebo with ranibizumab in people 50 and older with a specific form of wet age-related macular degeneration.

  Recruiting Phase 3 SANGMYUNG innovation · Seoul, Seoul · NCT07695207

• Early imaging changes with faricimab versus biosimilar ranibizumab for diabetic retinal disease

  This trial will see if faricimab or a biosimilar ranibizumab causes different early OCT and OCTA imaging changes in adults with diabetic retinopathy or diabetic macular edema who need anti-VEGF injections.

  Recruiting Osijek University Hospital · Osijek · NCT07520045

• Port Delivery System with ranibizumab refilled every 36 weeks for neovascular (wet) AMD

  This trial tests whether a refillable eye implant that delivers ranibizumab every 36 weeks works and is safe for people with recent neovascular (wet) age-related macular degeneration who responded to prior anti-VEGF injections.

  Recruiting at 63 sites Phase 3 Hoffmann-La Roche · Innsbruck and 63 other locations · NCT06847542

• Switching patients with AMD from ranibizumab or aflibercept to faricimab

  This study is testing if switching people with age-related macular degeneration from their current eye injections to a new treatment called faricimab can improve their vision and reduce the number of injections they need.

  Recruiting Nantes University Hospital · Nantes, Nantes · NCT06271330

• Long-term evaluation of a delivery system for eye treatment in age-related macular degeneration

  This study is testing a new delivery system for eye treatment to see if it is safe and effective for people with a specific type of age-related vision loss.

  Recruiting at 71 sites Phase 3 Hoffmann-La Roche · Phoenix, Arizona and 164 other locations · NCT03683251

• Switching from ranibizumab to aflibercept for eye conditions

  This study is testing if switching patients with certain eye conditions from one medication to another can help improve their vision.

  Recruiting Medical University of Vienna · Vienna · NCT02669953

Quick answers

How many clinical trials of Ranibizumab are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 22 countries. The most sites are in Austria (3 trials), France (3 trials), South Korea (2 trials), Germany (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →